Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syndrome-differentiated Chinese medicine granules for IBS-D
ChiCTR-TRC-13004553Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Jan 2013
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Placebo-COD Research Private Ltd in Diarrhea-predominant irritable bowel syndrome (IBS-D) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: IBS Symptom Severity Score. Started Jan 2013; status: recruiting.
02
Drugs
Placebo-COD Research Private Ltd
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on ChiCTR-TRC-13004553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13004553.